Zhang Lan Jun
Zhang Lan Jun — Chief Physician — Thoracic Surgery — Sun Yat-sen University Cancer Prevention and Treatment Center
Specialties
Diagnosis, Treatment, and Comprehensive Therapy of Breast Tumor Surgery
Education
Graduated from the Fourth Military Medical University in 1984, and after graduation, stayed at the university to teach while engaging in cardiovascular surgery clinical work at the Xijing Hospital of the Fourth Military Medical University and completing residency training in thoracic and cardiovascular surgery. In 1988, studied under China's renowned thoracic surgery expert Professor Liu Kun on esophageal function research and obtained a master's degree in medicine in 1991. In 2001, studied under the famous thoracic surgery expert Professor Rong Tiehua and obtained a doctoral degree in medicine in 2004.
Professional Experience
Professor, Chief Physician, PhD Supervisor, Postdoctoral Supervisor, Chief Expert in Lung Cancer. Graduated from the Fourth Military Medical University in 1984, and stayed at the university to teach after graduation while working in cardiovascular surgery at Xijing Hospital of the Fourth Military Medical University and completing residency training in cardiothoracic surgery. In 1988, studied under the famous thoracic surgeon Professor Liu Kun to conduct research on esophageal function and obtained a Master of Medicine degree in 1991. In 1991, served as lecturer and attending physician in thoracic surgery at Nanfang Hospital of the First Military Medical University. In 2001, studied under the well-known thoracic surgeon Professor Rong Tiehua and obtained a Doctor of Medicine degree in 2004. In 2004, stayed at Sun Yat-sen University to engage in clinical, teaching, and research work in thoracic surgery. In 2006, appointed Deputy Director of Thoracic Surgery at Sun Yat-sen University Cancer Center, promoted to Professor and Chief Physician in 2008, and has been Director of Thoracic Surgery since 2010. Since 1999, engaged in the construction of biomaterial artificial organs, including the development of artificial esophagus, artificial ribs, and artificial surgical patches. In July 2001, successfully performed the first human implantation of a biomaterial artificial esophagus domestically and internationally. Since December 2005, successfully applied biomaterial artificial chest walls for reconstruction after large defects caused by lung cancer invasion of the chest wall, post-empyema chest wall defects, and intrathoracic tumors with thoracic deformities; in 2018, received the ESTS-MEDXPERT award in Europe. In 2015, carried out the first electromagnetic navigation (ENB) procedure for diagnosis and treatment of small intrapulmonary nodules in South China. In 2016, performed the first robot-assisted radical lung cancer surgery in South China. In 2022, elected Fellow of the American Association for Thoracic Surgery (AATS), and since 2014 has been a member of the European Society of Thoracic Surgeons (ESTS) and the International Association for the Study of Lung Cancer (IASLC). Currently, mainly engaged in surgical treatment and comprehensive treatment research of lung cancer, early screening and diagnosis of lung cancer, prognosis prediction, minimally invasive and robotic surgery for lung cancer, molecular classification and targeted therapy of lung cancer; construction and application of biomaterial artificial organs; establishment of thoracic tumor specimen banks and tumor information platforms and translational research; screening of molecular markers for personalized tumor treatment; as well as postoperative nutritional support for thoracic tumor surgery and the impact of nutritional support on immunity in tumor patients. Has undertaken 4 major national 863 projects, multiple Guangdong Province and Guangzhou City scientific research and natural science fund projects, with nearly 6 million yuan in funding received. Currently, he is responsible for multiple ongoing international multicenter RCT clinical studies and domestic multicenter RCT clinical studies. He has published over 140 SCI articles as the first author or corresponding author and has edited or contributed to 9 monographs. Professor Zhang Lanjun led his department to receive the National Key Clinical Discipline Construction Project from the Ministry of Health in 2011, and successfully passed the national evaluation in 2017, obtaining the National Key Clinical Discipline (Thoracic Surgery). Currently, the department has ranked 6th-8th consecutively for 11 years in the national thoracic surgery clinical specialty ranking (Fudan University version). In 2014, he was awarded the title of the Second Session of Good Physician of Yangcheng, from 2016 to 2020 he repeatedly received the title of Lingnan Famous Doctor, and in 2019 he received the honor of the Third Session of the National Famous Doctor (Outstanding Style).
Professional Roles
Member of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association and Deputy Leader of the Lung Cancer Study Group (9th and 10th terms); Member of the Thoracic Surgery Branch of the Chinese Medical Doctors Association (1st-4th terms); Deputy Director of the Lung Cancer Expert Committee of the Thoracic Surgery Branch of the Chinese Medical Doctors Association (4th term); Deputy Director of the Trauma Expert Committee of the Thoracic Surgery Branch of the Chinese Medical Doctors Association (2nd and 3rd terms); Standing Committee Member of the Popular Science Committee of the Chinese Anti-Cancer Association (1st and 2nd terms); Member of the Lung Cancer Professional Committee of the Chinese Anti-Cancer Association (5th, 6th, and 7th terms); Member of the Esophageal Cancer Professional Committee of the Chinese Anti-Cancer Association (6th and 7th terms); Standing Committee Member of the Thoracoscopy Professional Committee of the Endoscopy Branch of the Chinese Anti-Cancer Association; Deputy Director of the Thoracic Surgery Branch of the Integrated Medicine Society of the Chinese Medical Doctors Association (1st term); Member of the Intelligent Medical Care Professional Committee of the Chinese Medical Doctors Association (2nd term); Director of the China Medical Promotion Association (2022); Deputy Director of the Thoracic Surgery Branch of the China Medical Promotion Association (2nd term); Deputy Director of the Smoking Control and Lung Cancer Prevention Professional Committee of the China Medical Promotion Association (1st and 2nd terms); Standing Committee Member of the Thoracic Oncology Branch of the China Medical Promotion Association (1st and 2nd terms); Deputy Director of the Lung Cancer Education Committee of the China Medical Education Association (1st term); Deputy Director of the Thoracic Surgery Professional Committee of the China Medical Education Association (1st term); Deputy Director of the Thoracic Surgery Branch of the Cross-Strait Medical and Health Exchange Association (1st and 2nd terms); Standing Committee Member of the Non-Small Cell Lung Cancer Professional Committee of the Chinese Society of Clinical Oncology (1st term); Chair of the Southern Alliance of the China Lung Cancer Surgical Alliance; Member of the National Physician Regular Examination Tumor Professional Committee; Member of the Lung Cancer Quality Control Expert Committee of the National Cancer Center (1st term); Member of the American Association for Thoracic Surgery (AATS) (elected 2022); Member of the European Society of Thoracic Surgeons (ESTS) (elected 2017); Member of the International Association for the Study of Lung Cancer (IASLC) (elected 2014); Member of the Rare Cancers Network (RCN) (elected 2011); Chair of the Thoracic Surgery Branch of the Guangdong Society of Biomedical Engineering (2nd term); Director of the Guangdong Society of Biomedical Engineering (11th term); Director of the Guangdong Chest Disease Society (1st term); Chief Health Expert of the Guangdong Provincial Committee (3rd, 4th, and 5th terms); Standing Committee Member of the Thoracic Surgery Branch of the Guangdong Medical Association (2nd term)